In February, Cheetah Medical Inc. raised $9 million in a late financing round to support commercialization of its NICOM (noninvasive cardiac output monitor) system, a continuous hemodynamic monitoring platform. [See Deal] Founded in 2001, the company has reached its commercialization phase at a time when its goals match that of hospital customers focused on solving their most costly problems, in particular, how to better manage patients in the intensive care unit, the hospital’s most expensive department.
The large strategics in critical care have clearly recognized the opportunity. Edwards Lifesciences Corp., the leader in hemodynamic monitoring, strengthened its internally developed invasive hemodynamic monitoring platform at the end of 2012 by acquiring private Dutch company BMEYE BV, the developer of a new noninvasive hemodynamic monitoring technology. [See Deal] (SeeAlso see "Edwards Acquires BMEYE, Gains Noninvasive Hemodynamic Monitoring" - In Vivo, 26 November, 2012.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?